|
- 积分
- 3
- 威望
- 3
- 包包
- 15
|
A review of gene and stem cell therapy in cutaneous wound healing 5 K1 k- q2 F+ m/ x1 b
A Stem Cell Niche for Intermediate Progenitor Cells of the Embryonic Cortex 1 u, F! R7 x L9 h5 E. y" l
Acute Complications of Stem Cell Transplant
; T) M6 S- @7 B7 n. @ U1 p9 KAdhesion within the stem cell niches ' ~& V2 J: a' ]: p( ^( A( Q
Allogeneic Stem Cell Transplantation Is Able to Induce Long-Term Remissions in Angioimmunoblastic T-Cell Lymphoma
' K. ?( C: c9 sBeliefs About Science and News Frames in Audience Evaluations of Embryonic and Adult Stem Cell Research
8 {7 [( ^1 { C: o7 V1 H% n# A) fbone-What is the true nature of the osteoblastic hematopoietic stem cell niche
: K# t2 p' P9 d0 J7 B5 Y9 }, W) P( i- Y1 sApoptosis signaling in cancer stem cells ) Z+ P: e+ v3 e! J
Nonmyeloablative and Reduced-Intensity Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation
( \0 G; m* z+ [9 M# cRecurrence cancer stem cells
; s1 u% g' T! b# _ aStem cells in melanoma development % V8 z+ N, D7 l& M$ {6 \: M
Competitive Interactions Between Cells 1 y5 ^$ `( j% J, L
Cord blood stem cells for hematopoietic stem cell transplantation in the UK . U' }2 Q5 P6 Q1 C& i# \
A chronic 1 year assessment of MRI contrast agent-labelled neural stem cell transplants in stroke
* ]5 t0 H2 |0 ~+ S( |0 d: C$ J" wCardiac stem-progenitor cells, secreted proteins, and proteomics 4 O; E# h$ A' `0 [) Y2 T
Cardiovascular stem cells in regenerative medicine
8 k% O2 ?2 z' `% T9 w3 tEndogenous stem cells in patients undergoing coronary artery bypass
[8 r3 U& r+ M" @4 A# P) Q* B+ o IEnhancing cardiac stem cell differentiation into cardiomyocytes
+ t; X2 P m# l* fIn Vivo Imaging of Stem Cells and Beta Cells Using Direct Cell Labeling and Reporter Gene Methods + C, Q2 `/ V/ v# \( U
Resident cardiac stem-progenitor cells for cardiac regeneration * w; K6 L: q9 T& ]1 K1 S0 F" v
S1+ Stem Cell Survival and Engraftment in the Infarcted Heart 2 `2 E" w& l7 W' \2 ^
Stem cell engineering for treatment of heart diseases
- w: r% s" s. D2 E3 oStem cell therapy in acute myocardial infarction
2 j+ ?+ z' c1 ]' e6 g' G$ I5 O% ZStem Cell Therapy Is Proarrhythmic 6 \( m0 q9 D3 t/ ?# W. a. b
Stem Cell Therapy-A Primer for Interventionalists and Imagers
c; J+ o, j& ^# r5 sdiabetes-Mesenchymal stem cells-Stem cell therapy perspectives for type 1 diabetes 5 V- m' e( C# t0 Q
Embryonic stem cells as a model for cardiac development and disease ! B0 S! L; M0 h
Epigenetic dynamics of stem cells and cell lineage commitment 3 L! Q6 u1 U" g" j5 N7 P7 N
Epileptic Spasms After Stem Cell Transplantation for Chronic Epstein-Barr Virus Infection Q) D; l: {6 X( T2 z8 @& P5 A& o7 F6 ?
Expanding Indications for Stem Cell Transplantation * N7 q a6 ]7 ]8 O* r' p. P7 i
Fatal nephrotic syndrome complicating allogeneic stem cell transplantation & N! d* V; f; Z
Growth Factors, Matrices, and Forces Combine and Control Stem Cells
3 Y% X/ @0 v! N4 w0 }% A3 e b- H/ VHematopoietic stem cell origin of adipocytes
% A2 z0 r) K n; THepatic response after high-dose melphalan and stem cell transplantation in patients with AL amyloidosis
d) Z9 }) p! C; P9 o, gLong-term microcarrier suspension cultures of human embryonic stem cells
' b0 r9 A6 C" _) hMicrosphere-based tracing and molecular delivery in embryonic stem cells
; {. V; {6 S% C1 C( _Microspheres as a vehicle for biomolecule delivery to neural stem cells
+ i b6 f+ c- R9 U+ Y( m+ _* uNew insights into liver stem cells
2 |4 j9 V% {: sA NEUROSURGEON'S GUIDE TO STEM CELLS, CANCER STEM CELLS, AND BRAIN TUMOR STEM CELLS
& d, G0 R2 x7 g/ ^$ aRegeneration of the ischemic brain by engineered stem cells
) ?. J! Q2 E8 Y) BStem cell-based cell replacement strategies for the central nervous system ! o0 s2 {6 W% E0 e
Percutaneous intramyocardial stem cell injection in patients with acute myocardial infarction
" f% H! W# R+ a4 v/ @ y9 a1 zPeripheral blood stem cell mobilisation by granulocyte-colony stimulating factor in patients with acute and old myocardial infarction
4 O- I u3 w" X: Y, D$ GPluripotent stem cells as new drugs
3 c! Q+ y0 \. r+ P Uregenerative-The complexity of cellular dedifferentiation-implications for regenerative medicine 3 m% Z. o7 J9 h) e9 u- b
respir-Cell therapy approaches for lung diseases ' J2 l5 l6 p( N, O$ Z
Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation
$ B3 V7 n# ^$ t- e6 q$ T* T- nRole of epigenetics in liver-specific gene transcription, hepatocyte differentiation and stem cell reprogrammation
: P6 y6 q4 Y3 p+ Y6 D! ~Role of Hematopoietic Stem Cell Transplant in the Management of Follicular Lymphoma
( R9 T& b3 d- Z t+ g% }9 `. i+ B. UStatus of adult marrow stem cell biology 5 d0 `2 ?: t, i
Stem cell and genetic therapies for the fetus
8 h' A) e" d7 v+ r* J. R) @4 [3 hStem cell decision making and critical-like exploratory networks
' V+ P5 f: R4 |7 z. R& iStem Cell Therapy for Heart Failure
" c' ^- e5 _& v+ wStem Cell Therapy for the Kidney + j2 \. H$ U& n- z. k8 i5 d n9 l
Stem Cells and Liver Regeneration
+ h# f- z/ p% O1 n. E5 vStem cells, microenvironment mechanics, and growth factor activation
6 F, W$ r6 M$ J. j, L' P9 q7 aStem cells-The highs and lows of pluripotency & S3 @3 J6 m/ k( A3 w7 w
Successful unrelated donor stem cell transplantation for advanced myelofibrosis in an adult patient with history of orthotopic liver transplantation
8 t" n; c$ [* L1 PSurvivorship Issues in Hematopoietic Stem Cell Transplantation
: u/ q5 y J6 h# b# |Telomere length maintenance in stem cell populations
% t4 q& M7 Q' f! vTeratoma formation by human embryonic stem cells : ~( q! P8 ?4 a! ~# R- D: g
The Development of Inflammatory Arthritis and Other Rheumatic Diseases Following Stem Cell Transplantation 9 K% @+ ?. V' u7 M k
The Increasing Complexity of the Cancer Stem Cell Paradigm
- C/ ] s8 c6 z4 U$ m$ h! jThe therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis
, i5 u" Y6 j1 x: d4 TTranscripts of unknown function in multiple-signaling pathways involved in human stem cell differentiation ; K: y# R+ r" ?
Variation in the safety of induced pluripotent stem cell lines x8 j7 Y+ g( r9 ^; B
A niche play for stem cells ; y& [) [' D0 E9 `1 z) |8 L2 A$ t' h4 u
A niche play for stem cells
6 P* r0 D/ N& c* I6 AA parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells
% h% I% k" q3 c) S) k% X, }Acute Complications of Stem Cell Transplant - M) c# X) Z, t2 I, k6 l& |
Adipose-Derived Stem Cells
5 J2 d: o* W EAdult neural stem cells in the mammalian central nervous system ! E: q7 X: p) \
Apoptosis Signaling in Cancer Stem Cells
$ l$ o- ?( l, O L& [7 @! }Automated selection and collection of pluripotent stem cell colonies using the CellCelector 2 E. b$ ^! N7 C# i9 Z2 P& }
BCOR regulates mesenchymal stem cell function by epigenetic mechanisms ; L8 ]5 ]( R! G6 K' v! w/ F
Bmi-1, stem cells and cancer
; r4 {6 W( v6 W! c+ }cancer stem cell marker 3 N" i! o9 m: N; E
Cancer stem cells
4 s5 f) T1 d8 SClinical Applications of Blood-Derived and Marrow-Derived Stem Cells for Nonmalignant Diseases
5 [, d9 C8 u* BCompetitive Interactions Between Cells-Death, Growth, and Geography
' a) @8 T/ K, v/ O" q) BPotential novel pharmacological therapies for myocardial remodelling # ]" j# x; R' ]6 N9 S! N. ?' W3 a' T
Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells
5 M& C8 w1 ?, T$ G8 X2 ^% DElite and stochastic models for induced pluripotent stem cell generation ! k b% d) S& k! t! ?- c4 e
Embryonic stem (ES) cell-derived cardiomyocytes
4 J% d5 V5 w) P' C8 j P- WEmerging Immunology of Stem Cell Transplantation . h9 b( z2 q L" _8 ]0 t
Ethical Issues in Stem Cell Research - [ v/ L$ g% @* j u" L
FDA Regulation of Stem Cell Based Products 1 V9 Z; L P( f! ?: ]& T
Growth Factors, Matrices, and Forces Combine and Control Stem Cells . F' j- y% c! Q+ `4 B
Human embryonic stem cells and cardiac repair $ {0 R* Z8 Q( M! E) R9 n
Human Fetal Membranes-A Source of Stem Cells for Tissue Regeneration and Repair ; \/ b/ k3 K3 {5 D/ t% v/ ?7 L; r
Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages
/ n# K3 h& h* r6 G: VIFN-wakes up sleeping hematopoietic stem cells % V5 y& h0 i1 d3 [) u# t l
Imaging Stem Cell Implant for Cellular-Based Therapies W9 ~8 X8 l% D' d$ |5 ~3 [
Implications of the Cancer Stem-Cell Hypothesis for Breast Cancer Prevention and Therapy 3 n3 L1 ^+ T1 X% X3 {
Induced pluripotent stem cells and the stability of the differentiated state
& e- R. G1 [+ k$ ~/ C# v1 LInstructing an Embryonic Stem Cell-Derived Oocyte Fate
1 A$ N- y* S" L# B# L+ R- TMedical Innovation Versus Stem Cell Tourism 4 r P& l3 ] t
In Search of Adrenocortical Stem and Progenitor Cells 6 }# `/ l6 V6 c% L( \# F4 a7 G1 e
Neural stem cells aplenty
2 ~7 c) d% e1 IPancreatic cancer stem cells
9 j& H$ }1 m4 k3 O x' |Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy
6 u5 m0 t A k& Y( b3 V+ KPsychological Issues of Stem Cell Transplant
% {, C. |6 n% L- \- i4 VRegeneration of the ischemic brain by engineered stem cells
e9 [0 V1 n' \Regulatory circuits underlying pluripotency and reprogramming
- \% \/ m2 r+ D- ~! J) A' {respir-Cell therapy approaches for lung diseases
" R* y; Q' B* |3 l. XRole of epigenetics in liver-specific gene transcription, hepatocyte differentiation and stem cell reprogrammation
) ~4 Z z. f$ u. O" |- [8 e, F5 kspecific microRNAs promote induced pluripotency # _; m \% Z: J+ C
Stem Cell Therapy for the Kidney 4 M: `1 h4 c; r" a( ~
stem cell therapy in cutaneous wound healing % w4 M8 l$ Q5 ]7 \
Stem cell therapy perspectives for type 1 diabetes
( `$ B+ f2 o3 ~3 m& RStem Cells and Liver Regeneration - o6 S6 {+ Y: e0 E1 [
Stem cells based transplantation for cardiovascular diseases in China
/ H2 n" f. z; C! hStem-cell therapy faces more scrutiny in China 0 U; N7 g3 R& g$ M" p/ e2 p( p4 d
Steps to the Clinic 1 q+ p n# ]9 P' C
Stepwise differentiation of pluripotent stem cells into retinal cells * x. s" b$ i2 D E8 t* U
Sustained in vitro intestinal epithelial culture within a Wnt-dependent stem cell niche $ P$ E& q2 `% y4 j! k
The Increasing Complexity of the Cancer Stem Cell Paradigm
* f* J+ H* q. s) U; v f% V9 u8 Q! nThe NIH Draft Guidelines on Human Stem Cell Research & [/ S% L5 i. r. U; F/ h! f
The pluripotency factor Oct4 interacts with Ctcf and also controls X-chromosome pairing and counting
: u! ~8 Z x& P5 ?) s: yThe Role of Stromal Stem Cells in Tissue Regeneration and Wound Repair
9 z- R/ _- Q- t3 AThe tumor stem cell concept
7 s; z7 x: y- [! W) HUmbilical cord blood stem cells-Towards a proteomic approach $ I; N2 \4 C, q) T0 u. M* H) q
US regulator wades into stem cell therapies for heart disease
0 d% W) o0 M4 n9 `; ^Apoptosis Signaling in Cancer Stem Cells
- @0 X& [3 ]1 M+ b/ XPancreatic cancer stem cells
4 y H6 W+ b; v0 F' o$ \. pAcute Complications of Stem Cell Transplant
! X+ {0 v2 [; i5 Q7 f, `5 O/ s8 e9 pAutologous Stem-Cell Transplantation in Patients With HIV-Related Lymphoma
; R6 y0 Z6 ]& q" T2 JDeconstructing Stem Cell Tumorigenicity-A Roadmap to Safe Regenerative Medicine ! ^& l) c* _+ c
Emerging Immunology of Stem Cell Transplantation 4 x% f; m5 K$ j- A
Management Issues In Hematopoietic Stem Cell Transplantation 1 o4 |( o. @0 X( A8 O: d
Psychological Issues of Stem Cell Transplant
& ^- I1 p! a" Q' t. W1 {The NIH Draft Guidelines on Human Stem Cell Research # E) t' \( j' L. q' t# Q
The therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis - N5 u, |- J& Y3 G) \
Bone Marrow-derived Stem-Progenitor Cells-Their Use in Clinical Studies for the Treatment of Myocardial Infarction 5 [1 I Q# M" r/ K* V
Embryonic stem (ES) cell-derived cardiomyocytes
% B+ F, x7 A$ v! fEmbryonic stem cells as a model for cardiac development and disease
! G9 s* c' j7 Y7 e5 g+ H5 EEndogenous stem cells in patients undergoing coronary artery bypass graft surgery
6 }( V& J; R6 g/ I+ a' O* HHuman embryonic stem cells and cardiac repair
% C; {+ c, U7 D$ G5 M7 ~Percutaneous intramyocardial stem cell injection in patients with acute myocardial infarction 6 b" O% ]. ^6 K# a: Q/ N* y3 B
Promise of Blood-and Bone Marrow-Derived Stem Cell Transplantation for Functional Cardiac Repair : y) R z+ N3 D
Stem Cell Therapy for Heart Failure
" h H! a' N w) w7 R8 f: n- @/ ZEpithelial metaplasia-adult stem cell reprogramming and (pre)neoplastic transformation mediated by inflammation 9 V4 W7 u8 F* I3 y% R s6 H
Full text access provided to Peking university
" Z- C1 v" ]) H1 j! F* e) kImproving stem cell mobilization strategies-future directions $ A; s& c* L/ w/ X0 H( Z
Induced pluripotent stem cells from a spinal muscular atrophy patient
5 T B7 | q" o5 B& T9 CInduced pluripotent stem cells-current progress and potential for regenerative medicine 3 H: q) z' M8 k1 h I
Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon鈥揹ependent exhaustion 8 A2 T( m3 t( a [1 L6 B. k
Low-risk reprogramming $ g6 N1 }8 b* k2 I$ e
Molecular cues for pluripotency, genetic reprogramming of adult stem cells, and widely multipotent adult cells ' C4 X+ ~, P! B/ a# h
piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells " V/ M6 B0 b1 [
Pluripotent stem cells as new drugs
8 k& t, r* T6 n! z( @proteome-Umbilical cord blood stem cells-Towards a proteomic approach ; j/ B2 J3 v7 A$ d ]3 Z5 U! g6 Q
Regeneration of the ischemic brain by engineered stem cells
2 G6 p& T/ Q- T; mResearchers Generally Happy With Final Stem Cell Rules % Q& d1 Y$ I- D* ^8 p$ I% c
Stem Cell Niche 7 i: x. W# a* f7 y& K/ w
Stem cell therapy perspectives for type 1 diabetes
+ E/ ~1 B6 V' X/ T/ G4 P9 M& G* i* PStem Cells and Liver Regeneration
' C' R5 v G0 y$ z" j! ~1 h; A( x0 I$ ?Stem cells-Fast and furious
1 B5 x, R% j; J K6 ~; n1 L bSurvivorship Issues in Hematopoietic Stem Cell Transplantation
" P: h& X% M) ]+ W* GThe NIH Draft Guidelines on Human Stem Cell Research
9 r/ {& n7 {* P u* \: i7 E$ d+ pThe origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases
; c% t* \8 ^% {) y Z5 K& CUS stem-cell research expands
$ [7 z5 @! ^; |Virus-free induction of pluripotency and subsequent excision of reprogramming factors
2 L% ^. _. Y c4 B# jWnt Signaling, Lgr5, and Stem Cells in the Intestine and Skin |
|
发表于 2009-10-29 19:08
